| nwamba # | Aha ngwaahịa | Nkọwa |
| CPD100464 | Erdafitinib | Erdafitinib, nke a makwaara dị ka JNJ-42756493, bụ onye nwere ike ma na-ahọrọ ọnụ ọnụ bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor nwere ike antineoplastic ọrụ. N'elu nchịkwa ọnụ, JNJ-42756493 na-ejikọta ma na-egbochi FGFR, nke nwere ike ịkpata nkwụsị nke ụzọ ntụgharị mgbaàmà metụtara FGFR ma si otú ahụ gbochie mmụba cell tumo na ọnwụ mkpụrụ ndụ tumo na FGFR-na-egosipụta oke mkpụrụ ndụ tumor. FGFR, nke edoziri n'ọtụtụ ụdị cell tumor, bụ tyrosine kinase nnabata nke dị mkpa maka mmụba cell tumor, ọdịiche na nlanarị. |
| CPD3618 | TAS-120 | TAS-120 bụ onye na-egbochi ọnụ nke bioavailable inhibitor nke fibroblast growth factor receptor (FGFR) nwere ọrụ antineoplastic nwere ike. FGFR inhibitor TAS-120 na-ahọrọ ma na-agbanweghi agbanwe na-ejikọta ma na-egbochi FGFR, nke nwere ike ịkpata nkwụsị nke ma ụzọ ntụgharị mgbaàmà nke FGFR na mmụba cell tumor, na ụbara ọnwụ cell na FGFR-na-egosipụta oke mkpụrụ ndụ tumor. FGFR bụ tyrosine kinase nnabata nke dị mkpa maka mmụba cell tumor, ọdịiche na nlanarị na okwu ya na-edozi n'ọtụtụ ụdị cell tumor. |
| CPDB1093 | Derazantib; ARQ-087 | Derazantinib, nke a makwaara dị ka ARQ-087, bụ onye na-emechi ọnụ nke ihe na-eme ka fibroblast growth factor receptor (FGFR) nwere ọrụ antineoplastic. |
| CPDB0942 | BLU-554 | BLU-554 bụ onye na-emechi ihe na-eme ka fibroblast na-anabata 4 (FGFR4) nwere ike ịgwọ ọrịa carcinoma hepatocellular na cholangiocarcinoma. |
| CPD0999 | H3B-6527 | H3B-6527 (H3 Biomedicine) bụ onye mmechi FGFR4 ahọpụtara nke ukwuu nwere ọrụ antitumour siri ike na ahịrị cell gbagoro agbagoro na ụmụ oke FGF19. |
| CPD0997 | FGF401 | FGF-401 bụ ihe mgbochi nke FGFR4 ewepụtara na patent WO2015059668A1, ihe atụ nke 83; nwere IC50 nke 1.9 nM. |
| CPDB0053 | AZD4547 | AZD 4547 bụ onye na-emechi nhọrọ nke fibroblast growth factor receptor (FGFR) tyrosine kinase nwere ụkpụrụ IC50 nke 0.2, 2.5, na 1.8 nM maka FGFR1, 2, na 3, n'otu n'otu. |
| CPD3610 | BLU-9931 | BLU9931 bụ onye nwere ike, nhọrọ na onye na-egbochi FGFR4 na-enweghị ike ịgbanwe ya na IC50 nke 3 nM, ihe dịka 297-, 184-, na 50-fold selectivity n'elu FGFR1/2/3, otu. |
